|
81 |
cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant
Enthalten in Acta neuropathologica Bd. 135, 1.3.2018, Nr. 4, date:4.2018: 639-642
|
|
|
|
82 |
cMyc and ERK activity are associated with resistance to ALK inhibitory treatment in glioblastoma
Enthalten in Journal of neuro-oncology Bd. 146, 28.11.2019, Nr. 1, date:1.2020: 9-23
|
|
|
|
83 |
Combined peritumoral radiomics and clinical features predict 12-month progression free survival in glioblastoma
Enthalten in Journal of neuro-oncology Bd. 174, 17.4.2025, Nr. 1, date:8.2025: 111-120
|
|
|
|
84 |
Concurrent gliomas in patients with multiple sclerosis
Enthalten in Communications medicine Bd. 3, 18.12.2023, Nr. 1, date:12.2023: 1-9
|
|
|
|
85 |
Das Deutsche Konsortium für Translationale Krebsforschung
Enthalten in Forum Bd. 36, 9.11.2021, Nr. 6, date:12.2021: 465-473
|
|
|
|
86 |
Deep intravital brain tumor imaging enabled by tailored three-photon microscopy and analysis
Enthalten in Nature Communications Bd. 15, 10.9.2024, Nr. 1, date:12.2024: 1-21
|
|
|
|
87 |
Deep-learning based detection of vessel occlusions on CT-angiography in patients with suspected acute ischemic stroke
Enthalten in Nature Communications Bd. 14, 15.8.2023, Nr. 1, date:12.2023: 1-15
|
|
|
|
88 |
DNA methylation-based epigenetic signatures predict somatic genomic alterations in gliomas
Enthalten in Nature Communications Bd. 13, 29.7.2022, Nr. 1, date:12.2022: 1-12
|
|
|
|
89 |
DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development
Enthalten in Acta Neuropathologica Communications Bd. 7, 25.4.2019, Nr. 1, date:12.2019: 1-18
|
|
|
|
90 |
DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastoma
Enthalten in Acta neuropathologica Bd. 144, 4.6.2022, Nr. 1, date:7.2022: 129-142
|
|
Administration
